Opaleye Management Inc. Synlogic, Inc. Transaction History

Opaleye Management Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.89 - $2.47 $875,938 - $2.43 Million	-984,200 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$1.63 - $2.55 $218,746 - $342,210	134,200 Added 15.79%	984,200 $2.36 Million
Q4 2021 Feb 14, 2022	BUY	$2.27 - $3.0 $1.93 Million - $2.55 Million	850,000 New	850,000 $2.06 Million
Q4 2017 Feb 09, 2018	SELL	$9.15 - $18.9 $2.29 Million - $4.73 Million	-250,000 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$11.55 - $21.79 $2.89 Million - $5.45 Million	250,000	250,000 $4.75 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $97.6M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Opaleye Management Inc., based on Form 13F filings with the SEC.

Stay updated on Opaleye Management Inc. with notifications on news.